Published on in Vol 12 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/64445, first published .

Review

1Division of Country Health Policies and Systems, World Health Organization Regional Office for Europe, Copenhagen, Denmark

2Technical University of Munich, TUM School of Medicine and Heath, Munich, Germany

3Center for Research in Epidemiology and Statistics (CRESS-U1153), Université Paris Cité and Université Sorbonne Paris Nord, INRAE, Hôpital Hôtel-Dieu, Paris, France

4School of Medicine, Faculdade de Ciências Médicas de Minas Gerais, Minas Gerais, Brazil

5Faculty of Health and Social Sciences, Western Norway University of Applied Sciences, Bergen, Norway

6School of Health Sciences, The University of Newcastle, Callaghan, Australia

7Institute of Health and Wellbeing, Federation University Australia, Melbourne, Australia

8Department for Evidence-based Medicine and Evaluation, University for Continuing Education Krems, Krems an der Donau, Austria

9Rio de Janeiro State University (UERJ), Núcleo de Estudos e Pesquisas em Atenção ao Uso de Drogas (NEPAD), Rio de Janeiro, Brazil

10Sports Medicine Unit, National Hospital of Kandy, Kandy, Sri Lanka

11Center for Research in Epidemiology and Statistics (CRESS-U1153), Université Paris Cité and Université Sorbonne Paris Nord, Inserm, Epidemiology of Childhood and Adolescent Cancers (EPICEA), Hôpital Paul Brosse AP-HP, Villejuif, France

12Directorate-General for Health and Food Safety, European Commission, Brussels, Belgium

13Geriatrics and Long-Term Care Department, Rumailah Hospital, Hamad Medical Corporation, Doha, Qatar

14Centre for Evidence-Based Medicine Odense (CEBMO) and Cochrane Denmark, Department of Clinical Research, University of Southern Denmark, Odense, Denmark

15Research Group of Urban Ageing, Faculty of Social Work and Education, The Hague University of Applied Sciences, The Hague, Netherlands

16Faculty of Spatial Management and Landscape Architecture, Department of Systems Research, Wrocław University of Environmental and Life Sciences, Wrocław, Poland

17School of Health, Wellbeing and Social Care, The Open University, Milton Keynes, United Kingdom

Corresponding Author:

David Novillo-Ortiz

Division of Country Health Policies and Systems

World Health Organization Regional Office for Europe

Marmorvej, 51

Copenhagen, 2100

Denmark

Phone: 45 45 33 7198

Email: dnovillo@who.int


Background: Dementia is a syndrome that compromises neurocognitive functions of the individual and that is affecting 55 million individuals globally, as well as global health care systems, national economic systems, and family members.

Objective: This study aimed to determine the status quo of scientific production on use of digital health technologies (DHTs) to support (older) people living with dementia, their families, and care partners. In addition, our study aimed to map the current landscape of global research initiatives on DHTs on the prevention, diagnosis, treatment, and support of people living with dementia and their caregivers.

Methods: A bibliometric analysis was performed as part of a systematic review protocol using MEDLINE, Embase, Scopus, Epistemonikos, the Cochrane Database of Systematic Reviews, and Google Scholar for systematic and scoping reviews on DHTs and dementia up to February 21, 2024. Search terms included various forms of dementia and DHTs. Two independent reviewers conducted a 2-stage screening process with disagreements resolved by a third reviewer. Eligible reviews were then subjected to a bibliometric analysis using VOSviewer to evaluate document types, authorship, countries, institutions, journal sources, references, and keywords, creating social network maps to visualize emergent research trends.

Results: A total of 704 records met the inclusion criteria for bibliometric analysis. Most reviews were systematic, with a substantial number covering mobile health, telehealth, and computer-based cognitive interventions. Bibliometric analysis revealed that the Journal of Medical Internet Research had the highest number of reviews and citations. Researchers from 66 countries contributed, with the United Kingdom and the United States as the most prolific. Overall, the number of publications covering the intersection of DHTs and dementia has increased steadily over time. However, the diversity of reviews conducted on a single topic has resulted in duplicated scientific efforts. Our assessment of contributions from countries, institutions, and key stakeholders reveals significant trends and knowledge gaps, particularly highlighting the dominance of high-income countries in this research domain. Furthermore, our findings emphasize the critical importance of interdisciplinary, collaborative teams and offer clear directions for future research, especially in underrepresented regions.

Conclusions: Our study shows a steady increase in dementia- and DHT-related publications, particularly in areas such as mobile health, virtual reality, artificial intelligence, and sensor-based technologies interventions. This increase underscores the importance of systematic approaches and interdisciplinary collaborations, while identifying knowledge gaps, especially in lower-income regions. It is crucial that researchers worldwide adhere to evidence-based medicine principles to avoid duplication of efforts. This analysis offers a valuable foundation for policy makers and academics, emphasizing the need for an international collaborative task force to address knowledge gaps and advance dementia care globally.

Trial Registration: PROSPERO CRD42024511241; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=511241

JMIR Ment Health 2025;12:e64445

doi:10.2196/64445

Keywords



Background

Dementia is a progressive neurocognitive syndrome currently cited as the seventh leading cause of death worldwide [Loy CT, Schofield PR, Turner AM, Kwok JB. Genetics of dementia. Lancet. Mar 01, 2014;383(9919):828-840. [CrossRef] [Medline]1]. This degenerative disease is also one of the leading causes of disability or dependency for aging populations today [GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. May 2019;18(5):459-480. [FREE Full text] [CrossRef] [Medline]2]. Dementia places a substantial burden on health care systems, national economies, and families, who often bear the responsibility of caregiving. Beyond the financial and logistical strain, individuals with dementia endure profound cognitive and neurological challenges, significantly affecting their quality of life [Aranda MP, Kremer IN, Hinton L, Zissimopoulos J, Whitmer RA, Hummel CH, et al. Impact of dementia: health disparities, population trends, care interventions, and economic costs. J Am Geriatr Soc. Jul 10, 2021;69(7):1774-1783. [FREE Full text] [CrossRef] [Medline]3]. In 2019, dementia affected over 55 million people globally and cost the world economy US $1.3 trillion. Nearly half of the financial burden was borne by informal caregivers [Wimo A, Seeher K, Cataldi R, Cyhlarova E, Dielemann JL, Frisell O, et al. The worldwide costs of dementia in 2019. Alzheimers Dement. Jul 08, 2023;19(7):2865-2873. [FREE Full text] [CrossRef] [Medline]4]. With no currently available cure [World Health Organization. World Health Organization endorses global action plan on rising incidence of dementia. Nurs Older People. Jun 30, 2017;29(6):7-7. [CrossRef] [Medline]5], efforts are focused on disease management, improving quality of life, and providing well-being support [Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. Aug 08, 2020;396(10248):413-446. [FREE Full text] [CrossRef] [Medline]6].

In recent years, the health care landscape has undergone a profound transformation with the integration of digital health technologies (DHTs), particularly the technologies applicable in the care of people living with dementia and their health care providers (formal and informal). Digital solutions offer novel avenues for enhancing medical care by supporting early diagnoses and implementing better preventive strategies [Senbekov M, Saliev T, Bukeyeva Z, Almabayeva A, Zhanaliyeva M, Aitenova N, et al. The recent progress and applications of digital technologies in healthcare: a review. Int J Telemed Appl. Dec 3, 2020;2020:8830200-8830218. [FREE Full text] [CrossRef] [Medline]7]. Furthermore, DHTs can potentially minimize the burden of care felt by family members, who often devote over 5 hours daily to providing care and supervision [Brookman R, Parker S, Hoon L, Ono A, Fukayama A, Matsukawa H, et al. Technology for dementia care: what would good technology look like and do, from carers’ perspectives? BMC Geriatr. Dec 16, 2023;23(1):867. [CrossRef]8]. Digital health interventions can offer a multifaceted approach to dementia treatment and prevention and revolutionize the modern approach to health care delivery and support in daily living. This comprehensive group of interventions covers multiple modalities of technologies, including artificial intelligence (AI), computer-based cognitive interventions and digital platforms, GPS, sensors for remote care, smart devices, mobile health, instant messaging applications, wearable devices, virtual reality, and telehealth [Classification of digital interventions, services and applications in health: a shared language to describe the uses of digital technology for health. 2nd edition. World Health Organization. URL: https://iris.who.int/bitstream/handle/10665/373581/9789240081949-eng.pdf?sequence=1 [accessed 2024-04-29] 9].

Recognizing the value of multidisciplinary research initiatives, the World Health Organization (WHO) Regional Office for Europe has taken a leading role in advancing scientific research in this area. Key initiatives have made significant contributions to exploring the intersection between digital health and healthy aging, including the United Nations Decade of Healthy Ageing (2021-2030) [WHO’s work on the UN decade of healthy ageing (2021-2030). World Health Organization. URL: https://www.who.int/initiatives/decade-of-healthy-ageing [accessed 2024-04-17] 10], the WHO Global Digital Health Strategy 2020 to 2025, the Regional Digital Health action plan for the WHO European Region 2023 to 2030, and the WHO European Framework for Action on Mental Health 2021 to 2025. Acknowledging the importance of its role, the WHO is committed to supporting the achievement of the sustainable development goals, specifically goal 3 (good health and well-being) and goal 9 (industry, innovation, and infrastructure) [Global sustainable development report 2023: times of crisis, times of change - science for accelerating transformations to sustainable development. United Nations. URL: https://sdgs.un.org/sites/default/files/2023-09/FINAL%20GSDR%202023-Digital%20-110923_1.pdf [accessed 2024-04-29] 11]. The research questions in this study aligned with 4 particular targets: reduce mortality from noncommunicable diseases and promote mental health (3.4), achieve universal health coverage (3.8), enhance research and upgrade industrial technologies (9.5), and universal access to information and communications technology (9.8) [Global sustainable development report 2023: times of crisis, times of change - science for accelerating transformations to sustainable development. United Nations. URL: https://sdgs.un.org/sites/default/files/2023-09/FINAL%20GSDR%202023-Digital%20-110923_1.pdf [accessed 2024-04-29] 11].

A protocol was published on February 19, 2024, which provided an overview of systematic and scoping reviews detailing how the analysis of different modalities of DHTs could improve the prevention, diagnosis, treatment, care, and support of (older) people living with dementia, their families, wider support network, and care partners [Comprehensive overview of digital health interventions for dementia: a synthesis of systematic and scoping reviews across prevention, diagnosis, treatment, and care support team. National Institute for Health Research. URL: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=511241 [accessed 2024-04-29] 12]. The research insights were drawn from a series of reviews on the topic and the numerous interventions for the holistic management of dementia, underscoring the necessity for compiling and summarizing the existing evidence in a solid and systematic document. As of April 2024, there has been a paucity of comprehensive, high-quality bibliometric analysis that examines the complete scope of research intersecting between the interface of DHTs and dementia care. Notably, compiling this bibliometric analysis provides valuable insights to identify areas for further investigation in granular detail, acting as a conduit for researchers working in areas of technology, gerontology, social science, gerontechnology, social research, and policy to initiate a route map based on the gaps in the literature.

This Review

This publication synthesizes the preliminary findings from the broad systematic search on February 21, 2024. This work will serve as a springboard for future investigations with a more detailed synthesis of specific modalities in digital health and how they relate to the 8 domains of the WHO’s Age-friendly Cities and Communities Framework. We anticipate that this series of documents will yield evidence beneficial to clinicians and policy makers alike working with people living with dementia.


Overview

Our study combines 2 methodologies within the field of evidence-based medicine as follows: (1) overview of systematic reviews and (2) bibliometric analysis. We combined both methodologies to leverage their complementary strengths in analyzing the complexity and evolution of DHTs in dementia care [Ellegaard O, Wallin JA. The bibliometric analysis of scholarly production: how great is the impact? Scientometrics. Jul 28, 2015;105(3):1809-1831. [CrossRef]13]. We initially used the principles of systematic reviews to obtain a broader number of studies, enabling the execution of the bibliometric analysis. The integration of both approaches provided a comprehensive and in-depth understanding of the current state of DHTs in dementia care—insights that neither method could achieve alone. This combined approach ensured rigorous and replicable evaluation of existing evidence from systematic reviews and also positioned our research within the broader context of global research trends.

This bibliometric analysis originated as part of the protocol published before the start of the reviewing process under the PROSPERO tracking locator CRD42024511241 [Comprehensive overview of digital health interventions for dementia: a synthesis of systematic and scoping reviews across prevention, diagnosis, treatment, and care support team. National Institute for Health Research. URL: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=511241 [accessed 2024-04-29] 12]. For this bibliometric analysis, we adhered to the guidelines for bibliometric studies, BIBLIO statement [Montazeri A, Mohammadi S, Hesari PM, Ghaemi M, Riazi H, Sheikhi-Mobarakeh Z. Preliminary guideline for reporting bibliometric reviews of the biomedical literature (BIBLIO): a minimum requirements. Syst Rev. Dec 15, 2023;12(1):239. [FREE Full text] [CrossRef] [Medline]14] and report the associated checklist as

Multimedia Appendix 1

BIBLIO checklist for reporting bibliometric reviews of biomedical literature.

DOCX File , 24 KBMultimedia Appendix 1. This analysis began with a large-scale review of 4839 articles retrieved from a comprehensive overview of systematic reviews, examining the current literature landscape at the interface of digital health and dementia. According to the international guidelines in evidence-based medicine, overviews of reviews are intended to evaluate the existing evidence from 2 or more reviews of different health interventions for a similar population or condition; they also assess these interventions across varying outcomes, settings, or time points [Hodgkinson B, Koch S, Nay R, Lewis M. Managing the wandering behaviour of people living in a residential aged care facility. Int J Evid Based Healthc. Dec 2007;5(4):406-436. [CrossRef] [Medline]15].

Article Search and Selection Strategy

This publication is a part of the project protocol using 2 primary techniques—systematic review and bibliometric analysis. In the first phase, we systematically searched 5 leading medical databases (MEDLINE, Embase, Scopus, Epistemonikos, and Cochrane Database of Systematic Reviews) for eligible systematic and scoping reviews. In collaboration with an expert committee, our information specialist designed a search strategy based on Medical Subject Headings and nonstandardized technical terms. In addition, the search was complemented by obtaining the first 300 hits from the Scholar (Google LLC) platform (source for gray literature) for eligible reviews from database inception until February 21, 2024, regardless of publication language. Search terms involved, but were not limited to, “dementia,” “Alzheimer disease,” “Lewy body dementia,” “mixed dementias,” “Huntington disease,” “multi-infarct dementia,” “vascular dementia,” and “major neurocognitive disorder.” Full access to the search strategy used in these preliminary findings is available in

Multimedia Appendix 2

Search strategies. The search was conducted on February 20, 2024.

DOCX File , 33 KBMultimedia Appendix 2.

Most investigators participated in the study selection phase, which was conducted independently by at least 2 investigators using the Covidence Systematic Review Platform (Veritas Health Innovation). The screening process was conducted in two stages as follows: (1) paper title and abstract and (2) full-text screening. Disagreements were resolved by a third investigator not involved in the initial screening process by evaluating the raised discrepancies compared to the inclusion criteria in the published protocol. Interrater reliability was noted to be average with a mean (SD) of 0.66 (0.31) and 0.57 (0.28) and median (IQR) of 0.58 (0.48-0.79) and 0.66 (0.54-0.77) for the screening stages, respectively, indicating moderate to strong reliability.

Using the PICOS framework, the search criteria for review analysis are described below.

  • Participants (P): reviews, including data from patients diagnosed with dementia (self-reported or clinically diagnosed by an individual or multidisciplinary team of medical and health care providers), regardless of the international classification used (for instance, International Classification of Diseases, Tenth Revision; International Classification of Diseases, Eleventh Revision; or Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition). In addition, those reviews focusing on the importance of DHTs for caregivers (formal or informal) of people living with dementia were shortlisted and evaluated.
  • Intervention (I): we included any modality of DHTs, telemedicine, telehealth, computerized decision support systems, clinical reminders or alert systems, home automation and monitoring systems, sensor-based systems and ambient intelligence, AI, mobile health, big data, 4G or 5G, exergaming, and the internet of things.
  • Comparator (C): no comparison group was prioritized. We included studies without any comparator, head-to-head comparisons, and placebo assessments.
  • Outcome (O): the Crosslingual Optimized Metric for Evaluation of Translation initiative was used to evaluate the existing “core outcome sets.”
  • Study design (S): systematic, rapid, and scoping reviews.

Systematic reviews that included more than one database search, in either narrative or quantitative format, were eligible. Moreover, scoping and rapid reviews were considered, categorized as “a review aiming to identify and map the available evidence, but that utilized a systematic methodological approach for including studies” [Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. Oct 02, 2018;169(7):467-473. [FREE Full text] [CrossRef] [Medline]16]. We excluded

narrative and integrative reviews (reviews without systematization of search and inclusion approaches) because they are more likely to report data in a highly biased pattern. Regarding the exclusion of narrative and integrative reviews, we would like to highlight several reasons [Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. Oct 02, 2018;169(7):467-473. [FREE Full text] [CrossRef] [Medline]16,Basheer A. The art and science of writing narrative reviews. Int J Adv Med Health Res. 2022;9(2):124-126. [CrossRef]17]. First, narrative reviews are highly prone to selection bias, as they typically do not systematically cover all relevant studies. Similarly, integrative reviews often lack the rigorous, standardized search and inclusion criteria that are fundamental to systematic and scoping reviews [Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. Oct 02, 2018;169(7):467-473. [FREE Full text] [CrossRef] [Medline]16,Basheer A. The art and science of writing narrative reviews. Int J Adv Med Health Res. 2022;9(2):124-126. [CrossRef]17]. Therefore, we excluded these types of publications to minimize potential inconsistencies and biases that could compromise the validity of our bibliometric analysis. [Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. Oct 02, 2018;169(7):467-473. [FREE Full text] [CrossRef] [Medline]16,Basheer A. The art and science of writing narrative reviews. Int J Adv Med Health Res. 2022;9(2):124-126. [CrossRef]17].

Bibliometric Analysis and Data Management

Following the initial identification of eligible reviews, a bibliometric analysis was conducted on the records that met our inclusion criterion. First, we downloaded eligible data from Covidence in a cvs format file to create our “primary library.” Raw cvs data were transformed into a relational Research Information System database, with the further exclusion of duplicates not primarily identified by Covidence (“secondary library”). After identifying unique records using their digital object identifier (DOIs), we created a matching “secondary library.” We then downloaded a comprehensive cvs file, which was further used for the bibliometric analyses.

This review used VOSviewer (version 1.6.20; Leiden University) to analyze the type of documents, years, authors, countries, institutions, journal sources, references, and keywords, allowing the creation of social network maps. VOSviewer uses probabilistic-driven normalization to ensure that the strengthen of relationships between nodes is accurately represented, accounting for differences in publication volumes and citations practices across various fields [Bukar UA, Sayeed MS, Razak SF, Yogarayan S, Amodu OA, Mahmood RA. A method for analyzing text using VOSviewer. MethodsX. Dec 2023;11:102339. [FREE Full text] [CrossRef] [Medline]18]. The projected clusters, each represented by a different color, suggest groups of related items that frequently cooccur in the literature, indicating underlying thematic connections [Bukar UA, Sayeed MS, Razak SF, Yogarayan S, Amodu OA, Mahmood RA. A method for analyzing text using VOSviewer. MethodsX. Dec 2023;11:102339. [FREE Full text] [CrossRef] [Medline]18]. The importance of these clusters lies in their ability to identify trending research topics, emerging trends, and potential gaps in the literature [Bukar UA, Sayeed MS, Razak SF, Yogarayan S, Amodu OA, Mahmood RA. A method for analyzing text using VOSviewer. MethodsX. Dec 2023;11:102339. [FREE Full text] [CrossRef] [Medline]18]. The total number of citations each year was obtained from the Scopus citation report. Social network analysis was set as the primary method used to analyze co-occurrence. Data associated with the journal’s impact factor (IF) were obtained from the Clarivate Journal Citation Reports (2022) and matched to the highlighted journals in our results section. From all variables prioritized in our study, corresponding data obtained from VOSviewer visualization analysis and calculations were also exported and tabulated on Microsoft Excel. VOSviewer uses probabilistic-based data normalization to create maps in fields like keywords, countries, and authors. These data were subsequently displayed in descriptive tables.

In bibliometrics, social network assessments are widely used to identify research hot spots and trends within specific scientific fields. The cluster findings were evaluated through VOSviewer to develop social network visualizations, demonstrating the relevance of the node size and line thickness. The nodes represent the number of occurrences or frequencies, while the observed lines between the nodes suggest relationships between nodes. A thicker line denotes a more substantial relationship between the nodal components, while a slimmer line denotes a weaker relationship and connection between nodes. The reported network analyses afford the visualization of trends in reviews on the interface between digital health and dementia.

Data management was performed predominantly in VOSviewer, which uses machine learning algorithms, processed input data related to study identification (title, authors, publication year, journal, and DOI), the number of citations and impact (citation count and IF of the journal in which the review was published), reported geographic regions attributed during indexation, departments and institutions declared during indexation, as well as main descriptors (standardized or nonstandardized indexation nomenclature).

Our bibliometric analysis is based on an overview of systematic and scoping reviews. Bibliometric analyses focus on quantifying publication patterns within a field, including the number of citations, authorships, coauthorship networks, institutional contributions, and keyword trends. Consequently, readers should not expect quality assessments of individual reviews, such as the use of AMSTAR tool.

Additional Data Processing and Categorization and Data Synthesis

In addition to our bibliometric assessment, a further classification of included reviews using a 3-step data assessment plan was conducted independently using Covidence. Each review was tagged for the number of primary studies reported in the manuscript (for instance, 0-10, 11-30, 31-60, 61-90, and 91-infinity), the modality of DHT being reported within the review, and if the record was a “systematic” or “scoping” review. We designed a focused analytic step of shortlisted studies to identify overviews intersecting between digital health and dementia. An additional filtering step was applied to identify records that had already used an overview methodology in their assessment. This step was introduced to avoid duplicating research efforts and to prioritize a more detailed exploration of modalities that have historically been less examined in the literature. This resulted in the identification of 14 records with the identifier “overview” or “umbrella,” as shown in

Multimedia Appendix 3

Identified overviews or umbrella reviews during the second screening phase.

DOCX File , 15 KBMultimedia Appendix 3.

Ethical Considerations

Ethics approval was waived as we used secondary, publicly available data.


Overview

A review flowchart diagram is shown in Figure 1. Complete details regarding the justification for the exclusion of the shortlisted studies is available in

Multimedia Appendix 4

Reasons for excluding shortlisted studies.

XLSX File (Microsoft Excel File), 31 KBMultimedia Appendix 4. Reasons for excluding shortlisted studies were primarily associated with conference papers (not published as full reports), protocols, reviews not focusing on DHTs, reviews of bioinformatics concepts, literature reviews, and studies not enrolling patients with dementia or cognitive impairment.

Figure 1. Review flowchart diagram. DOI: digital object identifier.

General Findings

Our results show the categorization of eligible reviews based on the number of primary studies, the modalities of DHTs reported within reviews, and the type of review (scoping or systematic review). Most of the included records were systematic reviews (537/663, 80.9%), while some scoping reviews were also registered (126/663, 19%). In addition, most reviews (346/663, 52.1%) included 11 to 30 primary studies (regardless of the study design). Notably, a lower number of records were allocated to the 31 to 60, 61 to 90, and ≥91 primary studies.

At the time of conducting the literature search, we ascertained that there were no published protocols of an overview of reviews (systematic or nonsystematic reviews), collating the available evidence of multiple modalities of DHTs pertaining to the integrated care of people living with dementia or any other related neurocognitive disorders or cognitive impairment disorders. This literature search is significant because of the volume of studies involved, including a substantial number of published overviews analyzing the relevance of DHTs in dementia care. While we assessed DHT modalities already covered in existing literature reviews, we placed particular emphasis on thoroughly examined less-explored modalities using our overview methodology. In doing so, we ensured a focused and detailed exploration of underrepresented areas. As part of this process, 14 records containing the term “overview” or “umbrella review” were identified in the tracked records (

Multimedia Appendix 3

Identified overviews or umbrella reviews during the second screening phase.

DOCX File , 15 KBMultimedia Appendix 3). These overviews, published after 2022, have been undertaken on people diagnosed with dementia to understand the effect of DHTs, such as wearable sensors, AI, virtual reality, eHealth, and web-based interventions. We did not include studies without a clear clinical, radiological, or any other deterministic form of diagnosing dementia on the patients under investigation in our analysis.

Bibliometric Analyses

A total of 755 references were included, and 52 reviews were duplicated (not primarily identified through automatic exclusion using the reference manager software), resulting in 704 references eligible for the bibliometric analysis. Furthermore, 12 references did not have a DOI identifier (

Multimedia Appendix 5

References without a digital object identifier.

DOCX File , 16 KBMultimedia Appendix 5), and 28 were not indexed in Scopus (

Multimedia Appendix 6

References not indexed in Scopus.

DOCX File , 18 KB
Multimedia Appendix 6
). Therefore, a total of 663 articles were downloaded into the cvs extension from Scopus, and visualization analysis was conducted.

Top Contributing and Co-Cited Journals

Table 1 and Figure 2 present our results on the authors with the most publications and the journals with the highest citations in the field of dementia and DHTs based on our included reviews. The Journal of Medical Internet Research had the highest number of reviews (34/663, 5.12%), with the highest citation count from all journals provided in the ranking (1052). Similarly, the Journal of Alzheimer’s Disease and the Cochrane Database of Systematic Reviews showed substantial metrics regarding published reviews and citation count. Note that the average publication year widely varied across ranked journals. The Ageing Research Reviews (IF_2022=13.1) was the journal with highest IF, while the lowest was the Geriatric Nursing (IF=2.7). Six distinct clusters were identified represented in red, green, blue, yellow, purple, orange, and cyan, each corresponding to a unique collaborative or thematic pattern. A complete analysis of the identified clusters is reported as a legend to Table 1.

As seen in Figure 2, the analysis of clusters revealed that cluster 1 (in red) included journals like Dementia, Disability and Rehabilitation: Assistive Technology, and Frontiers in Psychology, which focus on psychological, social, and rehabilitation features of dementia care, particularly the integration of dementia to assistive technologies. Cluster 2 (in green) contained journals like Healthcare (Switzerland) and Frontiers in Aging Neuroscience, which were likely to be associated with health care delivery and neuroscience aspects of dementia care, providing a focused and tailored analysis using medical and biological components attributed to DHTs. In cluster 3 (in blue), we observed the presence of highly influential journals like the Journal of Medical Internet Research and International Psychogeriatrics, whose primary focus relates to internet-based research, psychogeriatrics, and perhaps the broader implications of DHTs in dementia care. Cluster 4 (in yellow) featured journals like the Cochrane Database of Systematic Reviews and Ageing Research Reviews, representing evidence-based reviews and systematic approaches to aging and dementia, emphasizing the fundamental role of rigorous evidence synthesis in the development and validation of DHTs in dementia care. In cluster 5 (in purple), journals like International Journal of Nursing Studies and Journal of Clinical Medicine, were found, which mainly publish research focused on the clinical and nursing aspects of dementia care as well as their integration with DHTs into routine clinical practice. Cluster 6 (in cyan) contained journals like the Journal of Alzheimer’s Disease and Sensors, with a particular focus on the interface between dementia research and sensor technologies, potentially emphasizing the role of wearable and remote monitoring devices in dementia care. Finally, the small cluster 7 (in orange) represented a distinguished group of journals, highlighting specific thematic focus within the field of dementia care and DHTs.

Table 1. Most productive and most cited journals in the field of dementia and digital health technologies.
JournalClusterLinksTotal link strengthDocumentsCitationsNormalized number of citationsAverage citationsAverage normalized number of citations
Journal of Medical Internet Research (IFa=7.4)381534105233.96530.9410.999
Journal of Alzheimer’s Disease (IF=4.0)618412074318.72137.1500.936
Cochrane Database of Systematic Reviews (IF=8.4)4661886025.35747.7781.409
International Psychogeriatrics (IF=7.0)518511693616.99158.5001.062
International Journal of Geriatric Psychiatry (IF=4.0)315311483512.49859.6430.893
Ageing Research Reviews (IF=13.1)49161356721.86643.6151.682
Aging and Mental Health (IF=3.4)715271364912.20149.9230.939
BMCGeriatrics (IF=4.1)3241371213.86254.7691.066
International Journal of Environmental Research and Public Health (IF=4.6)711111049.4729.4550.861
Dementia (IF=4.1)110221019310.56119.3001.056
Disability and Rehabilitation: Assistive Technology (IF=N/Ab)171210628.9246.2000.892
JMIRAging (IF=4.9)159101285.86012.8000.586
Journal of the American Medical Directors Association (IF=7.6)111131078311.98778.3001.199
Health care (Switzerland) (IF=N/A)2339763.2868.4440.365
Journal of Clinical Medicine (IF=3.9)51191687.49718.6670.833
Frontiers in Aging Neuroscience (IF=4.8)222879513.44599.3751.681
Geriatric Nursing (IF=2.7)29138904.09911.2500.512
BMJOpen (IF=2.9)271674146.14459.1430.878
Gerontologist (IF=5.7)62571165.49216.5710.785
International Journal of Nursing Studies (IF=8.1)551371166.65816.5710.951
JMIR Serious Games (IF=4.0)13571289.20618.2861.315
Clinical Interventions in Aging (IF=3.6)171162213.76736.8330.628
International Journal of Medical Informatics (IF=4.9)42264177.72569.5001.288
Alzheimer’s and Dementia (IF=N/A)36755909.349118.0001.870
Frontiers in Psychology (IF=3.8)15652457.09549.0001.419
Journal of Clinical Nursing (IF=4.2)2445912.83818.2000.568
Sensors (IF=3.9)6365734.46314.6000.893

aIF: impact factor.

bN/A: not applicable.

Figure 2. Top contributing and co-cited journals.

Top Contributing Countries and Regions

Researchers from 66 countries published reviews on the intersection between dementia and DHTs, and Table 2 details the number of citations, documents, and the average number of publications per year, etc. The top 5 countries with evidence-based research in this arena are the United Kingdom (139/663, 20.9%), United States (105/663, 15.8%), Australia (66/663, 9.9%), Canada (61/663, 9.2%), and the Netherlands (53/663, 7.9%). Column 3 of Table 2 shows the country coauthorship networks, particularly evidencing the chord diagram of country cooperation networks ranked by total link strength (Figure 3). The United Kingdom had the highest number of total link strengths, followed by the United States, the Netherlands, Australia, and Switzerland (335, 155, 145, 142, 128, respectively). Countries with the highest number of citations included the United Kingdom (n=6004), United States (n=4911), Australia (n=3491), the Netherlands (n=2647), and Canada (n=1758). Cluster analysis identified 6 different research clusters within the intersection between DHTs and dementia care. Explanation related to identified clusters is available in Table 2.

As seen in Figure 3, cluster 1 (in red) shows that North America and East Asian countries are powerhouses on the research in the interface between DHTs and dementia care, cluster 2 (in green), represents diverse global contributors with a focus on European and South Asian countries, cluster 3 (in blue) suggests leaders in the European and Middle Eastern research hubs, cluster 4 (in yellow) flags Northern European and Nordic countries as research hubs, cluster 5 (in purple) represents Southern Europe and Middle Eastern countries as emerging players in research with growing interest in advancing research in the intersection of DHTs and dementia care, and cluster 6 (in cyan), represents smaller and more focused contributors with specific expertise (in terms of citations).

Table 2. Most prolific countries in the field of dementia and digital health technologies.
CountryClusterLinksTotal link strengthDocumentsCitationsNormalized number of citationsAverage citationsAverage normalized number of citations
United Kingdom3313351396004150.21943.1941.081
United States127155105491199.14646.7710.944
Australia12514266349188.94852.8941.348
Canada2258661175851.01128.8200.836
The Netherlands12414553264752.99249.9431.000
Italy5259849170951.74134.8781.056
China121684779736.75416.9570.782
Germany422803882932.88121.8160.865
South Korea120842872157.51625.7502.054
Spain2225927168243.56062.2961.613
Switzerland32812827101323.24737.5190.861
India2572654764.43721.0392.478
Ireland617251766517.86839.1181.051
Sweden419421768121.38640.0591.258
Hong Kong411201633712.89421.0630.806
Norway418541671615.06544.7500.942
Singapore112251631814.13019.8750.883
Portugal22035151337.1208.8670.475
France112241459515.00842.5001.072
Brazil71324131947.00314.9230.539
Taiwan316311326315.45120.2311.189
Belgium318541170112.53563.7271.140
Iran51326111488.83713.4550.803
Japan11124101435.80514.3000.581
New Zealand211188635.0087.8750.626
South Africa21126822014.49827.5001.812
Czech Republic2153661332.71722.1670.453
Qatar36206657.62410.8331.271
Greece56751398.01227.8001.602
Indonesia68105252.2815.0000.456
Kuwait36165596.93011.8001.386
United Arab Emirates3445655.84313.0001.169
Austria2224493.91412.2500.979
Finland43342495.42762.2501.357
Malaysia1554260.7286.5000.182
Figure 3. Most prolific countries in the field of dementia and digital health technologies.

Top Contributing Authors

Between 2002 and 2024, a total of 3076 authors have published reviews relating to the intersection between dementia and DHTs (Table 3), including authors who have published ≥3 papers. Seven (0.22%) researchers had published 5 documents based on the identified reviews (Rose-Marie Dröes, Julian Hirt, Minmin Leng, Meyer Gabriele, Ita Daryanti Saragih, Jing Wang, and Zhiwen Wang). Column 4 of Table 3 pertains to the author coauthorship networks, particularly related to the density visualization of the number of publications by the author (Figure 4). Some of the 63 (2.04%) authors in the network were not connected to each other, and the largest set of connected authors consisted of 31 (1%) authors. In Figure 4, the redder the color, the higher the number of publications from the determined investigator, and the closer the distance between authors, the greater the collaboration intensity. With regards to the total link strength between identified authors, the most substantial co-occurrence network was performed by Minmin Leng (n=11), Mingyue Hu (n=11), Julian Hirt (n=10), Li Chen (n=9), and Huiru Yin (n=9).

Table 3. The most prolific authors in the field of dementia and digital health technologies.
AuthorClusterLinksTotal link strengthDocumentsCitationsNormalized number of citationsAverage citationsAverage normalized number of citations
Dröes, Rose-Marie45551904.16138.0000.832
Hirt, Julian37105812.87316.2000.575
Leng, Minmin1111151734.72334.6000.945
Meyer, Gabriele36851372.42427.4000.485
Saragih, Ita Daryanti4885242.5914.8000.518
Wang, Jing6115592.92011.8000.584
Wang, Zhiwen1445983.34319.6000.669
Cooper, Claudia22244553.773113.7500.943
Hu, Mingyue1111142045.28751.0001.322
Koh, Wei Qi14441126.30728.0001.577
Lee, Bih-O4884222.1595.5000.540
Moyle, Wendy37741703.66442.5000.916
Robinson, Louise25541602.53940.0000.635
Woods, Bob633433114.95582.7503.739
Wu, Bei61141152.50928.7500.627
Beer, Thomas3783802.65726.6670.886
Budak, Kübra Beliz1663474.52315.6671.508
Casey, Dympna2553854.74128.3331.580
Chen, Li1993822.19127.3330.730
Felding, Simone Anna1663474.52315.6671.508
Feng, Hui42231394.21346.3331.404
Irazoki, Eider52331073.97035.6671.323
Jones, Cindy37731532.80851.0000.936
Livingston, Gill28834444.968148.0001.656
Meyer, Claudia2333412.36913.6670.790
Prosperini, Luca21131253.40741.6671.136
Roes, Martina3223333.81711.0001.272
Toribio-Guzmán, José Miguel52331073.97035.6671.323
Van Der Roest, Henriëtte5553954.08431.6671.361
Van Straten, Annemieke45531733.11157.6671.037
Yin, Huiru1993822.19127.3330.730
Figure 4. The most prolific authors in the field of dementia and digital health technologies.

Top Contributing Institutions

A total of 2218 institutions or academic departments (organizations) have produced reviews on the interface between dementia and DHTs (Table 4). The analysis evidenced that the College of Nursing, Kaohsiung Medical University, Kaohsiung in Taiwan (5/2218, 0.22% documents) and the Dementia Services Development Centre Wales, Bangor University, Bangor in the United Kingdom (4/2218, 0.18% documents) were the most productive centers in the field of digital health and telemedicine. In relation to the highest total number of citations from each organization, 3 (0.13%) institutions from the Netherlands had the highest citation number (n=396). These institutions are Delft University of Technology, Delft Bio-Robotics Lab, in Delft, Maastricht University, Care and Public Health Research Institute, in Maastricht, and Zuyd University of Applied Sciences, Research Centre for Technology in Care, in Heerlen. Column 5 presents the institution coauthorship networks and the chord diagram of the institution cooperation network. In Figure 5, it is worth reiterating that the size of the nodes represents the number of publications per institution. The distance between each node as well as the thickness of the link represents the strength of cooperation between institutions. Cluster analysis is fully described in Table 4. However, the identified clusters represent 1 (in red) institution leading in technological innovation and multidisciplinary research in DHTs; 2 (in green) institutions that focuses on health care implementation, gerontology, and ethics; and 3 (in blue) institutions at the intersection of nursing and applied psychology.

Table 4. The most prolific organizations in the field of dementia and digital health technologies.
OrganizationClusterLinksTotal link strengthDocumentsCitationsNormalized number of citationsAverage citationsAverage normalized number of citations
College of Nursing, Kaohsiung Medical University, Kaohsiung, Taiwan3111152425.9124.80.5182
Dementia Services Development Centre Wales, Bangor University, Bangor, United Kingdom2774264145.7136636.428
International Graduate Academy, Institute for Health and Nursing Science, Medical Faculty, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany2202724315.23421.50.7617
School of Nursing, Jilin University, Changchun, China1131326817.222340.8611
Center for The Interdisciplinary Study of Gerontology and Vulnerability (Cigev), University of Geneva, Geneva, Switzerland2161612412.0952412.095
Delft University of Technology, Delft Bio-Robotics Lab, Delft, Netherlands11010139622.69339622.693
Depart of Geriatrics, University of Basel, Switzerland267116420.04616420.046
Department of Artificial Intelligence, Korea University, Seoul, South Korea177140.864340.8643
Department of Computer Science, Humantech Institute, University of Applied Sciences and Arts Western Switzerland, Fribourg, Switzerland267116420.04616420.046
Department of Developmental Psychology, Tilburg University, Tilburg, The Netherlands2161612412.0952412.095
Department of Health Policy and Management, College of Health Sciences, Korea University, South Korea177140.864340.8643
Department of Management, Technology and Economics, Eth Zürich, Zurich, Switzerland3121210000
Department of Pharmacology, College of Basic Medical Sciences, Jilin University, Changchun, China1131316510.7396510.739
Department of Psychology, University of Geneva, Geneva, Switzerland2161612412.0952412.095
Division of Health and Medical Sciences, The Cyber University of Korea, Seoul, South Korea177140.864340.8643
Fooder Ltd, London, United Kingdom267116420.04616420.046
Institute for Biomedical Ethics, Faculty of Medicine, University of Basel, Basel, Switzerland267116420.04616420.046
Institute for Health and Society, Medical College of Wisconsin, Milwaukee, WI, United States267116420.04616420.046
Institute for Implementation Science in Health Care, University of Zurich, Zurich, Switzerland3121210000
Institute of Biomedical Ethics and History of Medicine, University of Zurich, Zurich, Switzerland3121210000
Institute of Technology Management, University of St Gallen, St Gallen, Switzerland3121210000
Maastricht University, Care and Public Health Research Institute, Maastricht, The Netherlands11010139622.69339622.693
Salomons Centre For Applied Psychology, Canterbury Christ Church University, Kent, United Kingdom3551720.8801720.8801
School of Mechanical Science and Engineering, Jilin University, Changchun, China1131316510.7396510.739
School of Nursing and Midwifery, University of Wollongong, Wollongong, Australia144117616.65117616.651
School of Nursing, Southern Medical University, Guangzhou, China1131316510.7396510.739
School of Psychology, University of Wollongong, Wollongong, Australia144117616.65117616.651
Swiss National Center of Competences in Research Lives—Overcoming Vulnerability, Life-Course Perspectives, Lausanne and Geneva, Switzerland2161612412.0952412.095
The First Hospital of Jilin University, Changchun, China1131316510.7396510.739
Transdisciplinary Major in Learning Health Systems, Department of Public Health Science, Graduate School, Korea University, South Korea177140.864340.8643
University Center for Legal Medicine, University of Geneva, Switzerland267116420.04616420.046
University Center for Medicine of Aging, Felix Platter Hospital, Basel, Switzerland267116420.04616420.046
University of St Gallen, St Gallen, Switzerland3121210000
Zuyd University, Research Centre for Technology in Care, Heerlen, The Netherlands11010139622.69339622.693
Figure 5. The most prolific organizations in the field of dementia and digital health technologies.

Analysis of Co-Occurring Keywords

On the basis of the co-occurrence network, a total of 2808 indexed keywords were found with each keyword being used at least 20 times. Table 5 illustrates the keyword co-occurrence network of reviews focusing on dementia and DHTs. The network map contains 5 clusters of 101 items, 4159 links, and 43,365 total link strengths. “Human” was the most frequently occurring keyword (523/2808, 18.63%), followed by “dementia” (385/2808, 13.71%), “systematic review” (327/2808, 11.65%), “review” (327/2808, 11.65%), and “aged” (181/2808, 6.45%). Table 5 presents the top 97 indexed keywords. These keywords are divided into 5 clusters (Figure 6), and its highlighted topographical zones.

Table 5. Top 97 most frequently used keywords.
Indexed termClusterLinksTotal link strengthOccurrencesAverage citationsAverage normalized number of citations
Human196528852338.9711.0128
Dementia196382338535.4940.890
Systematic review196393832743.8101.082
Review196355929741.0031.060
Aged296228518139.7071.014
Cognitive defect296199715538.0321.041
Alzheimer disease396183515239.2431.190
Quality of life190169214532.4350.921
Caregiver181135913840.2900.886
Meta-analysis295165513332.6991.013
Psychology190140912645.3100.885
Cognition295162011741.6151.172
Mild cognitive impairment395162111344.4601.168
Cognitive dysfunction292130410133.1881.059
Depression19111679046.8671.137
Female29612878723.2530.864
Male29612248323.1690.843
Article3969577553.2131.103
Procedures4968517464.9461.279
Priority journal5958317062.7431.000
Adult2949096519.4150.917
Daily life activity2898466535.6621.082
Outcome assessment1948326449.3441.008
Virtual reality2917786129.7710.933
Clinical effectiveness4887805659.1961.086
Telemedicine1946425641.1431.026
Neurodegenerative diseases3773315317.6981.042
Mini Mental State Examination2947464839.0631.155
Social support1735424849.9380.960
Machine learning3755244451.7731.959
MEDLINE5916034431.0680.887
Randomized controlled trials as topic4785944454.9550.979
Executive function2706164353.3261.369
Technology1833944326.1160.745
Aging1935454242.8571.059
Anxiety1855334246.6671.204
Health care delivery1793923826.2900.949
Memory2805393848.3421.185
Middle aged2825393854.8681.142
Quality control1935583846.4741.152
Very elderly2845863740.8111.046
Artificial intelligence3654053624.9721.400
Deep learning3564063634.4172.717
Interpersonal communication1774163638.3061.286
Mental health1784173651.5831.311
Neuroimaging3624553648.1391.682
Nuclear magnetic resonance imaging3704653532.4571.535
Patient care1863903552.2291.962
Sensitivity and specificity3694543521.9141.045
Treatment outcome4754563577.0291.380
Activities of daily living2784393325.8490.802
Mental disease1804143345.3331.195
Social interaction1714363340.3031.188
Cognitive therapy4784383294.6881.348
Parkinson disease3834223230.3441.305
Aged ≥80 years2794373065.3671.024
Caregiver burden1694103044.1331.127
Diagnostic accuracy3694143057.7331.518
Physical activity4833942938.4481.059
Exercise4693592863.9641.193
Nursing home1733582826.1430.616
Telehealth1733532839.7140.736
Internet1743072756.0001.012
Robotics1682992755.8891.106
Assistive technology1672742640.4230.796
Nursing1622922644.6150.817
Preferred Reporting Items for Systematic Reviews and Meta-Analyses382344266.1150.484
Qualitative research1733072622.5770.689
Working memory2774102641.7690.918
Agitation4643422561.8401.093
Cerebrovascular accident2732942531.201.048
Controlled study2844092524.601.343
Follow-up2823542535.6401.365
Neuropsychological test2673382564.0801.223
Practice guideline5833252541.4801.052
PsycINFO5773802536.5600.806
Self-help devices1492052557.4000.956
Clinical outcome1853652425.6250.872
Data extraction1843102424.5420.975
Health care personnel1802662414.4580.655
Independent living1743092442.5420.994
Cognitive rehabilitation2683322340.3040.818
Convolutional neural network3543262347.0002.377
Data base1823032327.0440.958
Music therapy4582662373.5650.992
Risk factor3762572336.0871.170
Diagnostic imaging3472562231.7271.665
Disease severity4753332255.2271.430
Early diagnosis3642512236.2270.973
Embase5793282228.5000.636
Montreal cognitive assessment2773512218.2270.989
Support vector machine3602952231.7731.276
Artificial neural network3592932136.0001.459
Intervention study4712712151.3330.793
Biological marker3572392048.0001.800
Information processing1862822049.5501.377
Positron emission tomography3562842052.9501.631
Figure 6. Analysis of co-occurring keywords.

As seen in Figure 6, cluster 1 (in red) represents all technological innovation and multidisciplinary research groups, characterized by groundbreaking institutions at the forefront of technological innovation in DHTs. Cluster 2 (in green) includes institutions that represent health care implementation, gerontology, and ethical considerations, while cluster 3 (in blue) represents evidence groups working on the interface of nursing and applied psychology groups.

Analysis of Reference Co-Citation Network

In 663 reviews analyzing the interface between dementia and DHTs, 42,758 references were cited (Figure 7). On the basis of the statistical assessments performed on VOSviewer to create our co-citation network (parameters: 3 for a minimum number of citations of cited references), 439 (1.02%) cited references were identified. Some of the 439 cited references in the obtained network were not connected. The most extensive set of connected references was 433 (1.01%) (Figure 7). Table 6 presents the top 15 most cited references among the 663 included reviews. The most cited reference was by the WHO, titled “Dementia: a public health priority,” published in 2012 [Dementia: a public health priority. World Health Organization and Alzheimer’s Disease International. URL: https://iris.who.int/bitstream/handle/10665/75263/9789241564458_eng.pdf?sequence=1%3E [accessed 2024-04-29] 19].

Figure 7. Analysis of cited references (the top 20 most cited references among the included reviews).
Table 6. Analysis of cited references (the top 15 most cited references among included reviews)a.
Reference locatorClusterLinksTotal link strengthCitations
1. Dementia: a public health priority [Dementia: a public health priority. World Health Organization and Alzheimer’s Disease International. URL: https://iris.who.int/bitstream/handle/10665/75263/9789241564458_eng.pdf?sequence=1%3E [accessed 2024-04-29] 19]6353815
2. Arksey H, O’Malley L. Scoping studies: towards a methodological framework [Arksey H, O'Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. Feb 2005;8(1):19-32. [CrossRef]20]2648234
3. Diagnostic and Statistical Manual Of Mental Disorders [American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5th edition. New York, NY. American Psychiatric Publishing; 2013. 21]4515413
4. Arksey H, O\'Malley L. Scoping studies: towards a methodological framework [Dementia: a public health priority. World Health Organization and Alzheimer’s Disease International. URL: https://iris.who.int/bitstream/handle/10665/75263/9789241564458_eng.pdf?sequence=1%3E [accessed 2024-04-29] 19]6323612
5. Kales HC et al. Assessment and management of behavioral and psychological symptoms of dementia [Kales HC, Gitlin LN, Lyketsos CG. Assessment and management of behavioral and psychological symptoms of dementia. BMJ. Mar 02, 2015;350:h369. [FREE Full text] [CrossRef] [Medline]22]4252611
6. Cohen J. Statistical Power Analysis For The Behavioral Sciences [Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd edition. New York, NY. Routledge Academic; 1988. 23]4475019
7. Moher D et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement [Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. Jul 21, 2009;6(7):e1000097. [FREE Full text] [CrossRef] [Medline]24]3546020
8. Global action plan on the public health response to dementia 2017-2025 [Global action plan on the public health response to dementia 2017-2025. World Health Organization. URL: https:/​/www.​who.int/​publications/​i/​item/​global-action-plan-on-the-public-health-response-to-dementia-2017-2025 [accessed 2025-01-12] 25]26310415
9. Global action plan on the public health response to dementia 2017-2025 [Global action plan on the public health response to dementia 2017-2025. World Health Organization. URL: https:/​/www.​who.int/​publications/​i/​item/​global-action-plan-on-the-public-health-response-to-dementia-2017-2025 [accessed 2025-01-12] 25]132388
10. Arksey H, O’Malley L. Scoping studies: towards a methodological framework [Dementia: a public health priority. World Health Organization and Alzheimer’s Disease International. URL: https://iris.who.int/bitstream/handle/10665/75263/9789241564458_eng.pdf?sequence=1%3E [accessed 2024-04-29] 19]235518
11. Bemelmans R et al. How to use robot interventions in intramural psychogeriatric care: a feasibility study [Bemelmans R, Gelderblom GJ, Jonker P, de Witte L. How to use robot interventions in intramural psychogeriatric care: a feasibility study. Appl Nurs Res. May 2016;30:154-157. [CrossRef] [Medline]26]238518
12. Lampit A et al. Computerized cognitive training in cognitively healthy older adults: a systematic review and meta-analysis of effect modifiers [Lampit A, Hallock H, Valenzuela M. Computerized cognitive training in cognitively healthy older adults: a systematic review and meta-analysis of effect modifiers. PLoS Med. Nov 2014;11(11):e1001756. [FREE Full text] [CrossRef] [Medline]27]329448
13. Moher D et al. preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement [Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. Jul 21, 2009;6(7):e1000097. [FREE Full text] [CrossRef] [Medline]24]228427
14. Mordoch E et al. Use of social commitment robots in the care of elderly people with dementia: a literature review [Mordoch E, Osterreicher A, Guse L, Roger K, Thompson G. Use of social commitment robots in the care of elderly people with dementia: a literature review. Maturitas. Jan 2013;74(1):14-20. [CrossRef] [Medline]28]220247
15. Moyle W et al. Effect of a robotic seal on the motor activity and sleep patterns of older people with dementia, as measured by wearable technology: a cluster-randomised controlled trial [Moyle W, Jones C, Murfield J, Thalib L, Beattie E, Shum D, et al. Effect of a robotic seal on the motor activity and sleep patterns of older people with dementia, as measured by wearable technology: a cluster-randomised controlled trial. Maturitas. Apr 2018;110:10-17. [FREE Full text] [CrossRef] [Medline]29]119217
16. Ouzzani M et al. Rayyan-a web and mobile app for systematic reviews [Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. Dec 05, 2016;5(1):210. [FREE Full text] [CrossRef] [Medline]30]6353815
17. Bemelmans R et al. How to use robot interventions in intramural psychogeriatric care: a feasibility study [Bemelmans R, Gelderblom GJ, Jonker P, de Witte L. How to use robot interventions in intramural psychogeriatric care: a feasibility study. Appl Nurs Res. May 2016;30:154-157. [CrossRef] [Medline]26]2648234
18. Abdi J et al. Scoping review on the use of socially assistive robot technology in elderly care [Abdi J, Al-Hindawi A, Ng T, Vizcaychipi MP. Scoping review on the use of socially assistive robot technology in elderly care. BMJ Open. Feb 12, 2018;8(2):e018815. [FREE Full text] [CrossRef] [Medline]31]4515413
19. Astell AJ et al. Technology and dementia: the future is now, dementia and geriatric cognitive disorders [Astell AJ, Bouranis N, Hoey J, Lindauer A, Mihailidis A, Nugent C, et al. Technology and Dementia Professional Interest Area. Technology and dementia: the future is now. Dement Geriatr Cogn Disord. 2019;47(3):131-139. [FREE Full text] [CrossRef] [Medline]32]6323612
20. Page MJ et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews [Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. Mar 29, 2021;372:n71. [FREE Full text] [CrossRef] [Medline]33]4252611

aOf note, we observed the existence of duplicated references not primarily identified through the software use for performing our bibliometric analysis (VOSviewer). Thus, we consolidated the reported metrics accordingly whenever needed (links, total link strength, and citations) into a single entry to ensure the most accurate representation within the cocitation network assessment.


Principal Findings

Overview

This primary review describes a high-level bibliometric insight into the literature on the existing DHTs and dementia care between 2002 and 2024. An increasing number of reviews (either systematic or scoping) have been published in medical- and technology-related scientific journals (704/704, 100% records). The included reviews suggest that the number of publications covering the intersection of digital health and dementia has increased steadily over time (compound annual growth rate of 26%), with some fluctuations. However, our observations highlight how several research initiatives released in indexed journals have covered similar modalities of digital technologies and research questions. Our findings align with trends reported in several studies, showing that the proliferation of reviews on a single topic leads to duplicated efforts and underscores the need for greater accountability to reduce research waste [Lund H, Juhl C, Christensen R. Systematic reviews and research waste. Lancet. Jan 09, 2016;387(10014):123-124. [CrossRef] [Medline]34]. In addition, our data highlight the concentration of research originating from high-income settings, presenting an opportunity for broader reflection on the implications of population aging within these countries.

Implications for Dementia Care

The challenges associated with the care of people living with dementia, as well as their caregivers, highlight the need for policy makers to reinforce adequate interventions in dementia care delivery. This review serves as a primary, high-level resource for policy makers and academics to enable them to understand and address the growing challenges in dementia care. As reported in the identified overviews of specific modalities of DHTs, multiple digital interventions pose as relevant tools for improving the health-related outcomes of people living with dementia and their caregivers. For instance, multidomain online lifestyle programs have been reported to not only positively affect population brain health outcomes but also potentially contribute to the prevention of dementia (based on findings from the Lifestyle Enrichment for Alzheimer Prevention program) [Wesselman LM, Hooghiemstra AM, Schoonmade LJ, de Wit MC, van der Flier WM, Sikkes SA. Web-based multidomain lifestyle programs for brain health: comprehensive overview and meta-analysis. JMIR Ment Health. Apr 09, 2019;6(4):e12104. [FREE Full text] [CrossRef] [Medline]35]. One overview investigating the role of eye-tracking technologies in evaluating eye movements and pupillometry parameters during different stages of dementia (using machine learning algorithms) suggested the potential for early diagnosis and the monitoring of cognitive decline, in addition to predicting the risk of developing dementia long-term [Ionescu A, Ştefănescu E, Strilciuc S, Grad DA, Mureşanu D. Eyes on dementia: an overview of the interplay between eye movements and cognitive decline. J Med Life. May 2023;16(5):642-662. [FREE Full text] [CrossRef] [Medline]36]. Likewise, wearable technologies and sensors (including environmental sensor-based systems and video systems) are suggested to reduce falls and fall risk for people living with dementia or mild cognitive impairment [Eost-Telling C, Yang Y, Norman G, Hall A, Hanratty B, Knapp M, et al. Digital technologies to prevent falls in people living with dementia or mild cognitive impairment: a rapid systematic overview of systematic reviews. Age Ageing. Jan 02, 2024;53(1):23. [FREE Full text] [CrossRef] [Medline]37].

Limitations in Current Research Approaches

Findings from this bibliometric review have ascertained the high number of reviews evaluating the impact of DHTs on dementia care. However, we have considered that there are limitations pertaining to the evidence-making process, which might not prove adequate. We found several reviews covering similar research questions (such as reviews evaluating the use of exergaming or AI in dementia care), exploring equivalent methodological approaches (such as similar research questions and eligible populations), and even underlying parallel outcomes of interest. For instance, 3 systematic reviews published in 2017, 2020, and 2023 investigated the impact of exergames on individuals with cognitive impairment to minimize the thematic level [Cai Z, Ma Y, Li L, Lu GZ. Effects of exergaming in older individuals with mild cognitive impairment and dementia: a systematic review and meta-analysis. Geriatr Nurs. May 2023;51:351-359. [CrossRef] [Medline]38-Zhao Y, Feng H, Wu X, Du Y, Yang X, Hu M, et al. Effectiveness of exergaming in improving cognitive and physical function in people with mild cognitive impairment or dementia: systematic review. JMIR Serious Games. Jun 30, 2020;8(2):e16841. [FREE Full text] [CrossRef] [Medline]40]. While the selected cases held slightly different foci, the core elements proved virtually identical, particularly the results, interpretations, and future directions for research stakeholders. This finding echoes the concerns stressed by multiple evidence producers, highlighting the potential for research redundancy in the reported results [Katsura M, Kuriyama A, Tada M, Yamamoto K, Furukawa TA. Redundant systematic reviews on the same topic in surgery: a study protocol for a meta-epidemiological investigation. BMJ Open. Aug 21, 2017;7(8):e017411. [FREE Full text] [CrossRef] [Medline]41-Moher D. The problem of duplicate systematic reviews. BMJ. Aug 14, 2013;347(aug14 4):f5040. [CrossRef] [Medline]44]. We recommend several strategies to address this concern, emphasizing that future research on digital health in dementia care should build on existing evidence and explore complementary knowledge gaps. In addition, we advocate for the use of standardized guidelines for conducting systematic reviews, such as those in the Cochrane Handbook of Systematic Reviews and other authority sources in the field [Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series. New York, NY. The Cochrane Collaboration; 2022. 45]. Avoiding research duplication can be facilitated by creating a centralized research database that serves as a repository for ongoing and complemented initiatives. This would help investigators worldwide to identify knowledge gaps and prevent redundant efforts [Zhang YH, Jia X, Lin H, Tan X. Be careful! Avoiding duplication: a case study. J Zhejiang Univ Sci B. Apr 2013;14(4):355-358. [FREE Full text] [CrossRef] [Medline]46,Hammer B, Virgili E, Bilotta F. Evidence-based literature review: de-duplication a cornerstone for quality. World J Methodol. Dec 20, 2023;13(5):390-398. [FREE Full text] [CrossRef] [Medline]47]. Moreover, fostering research collaboration and communication through interdisciplinary partnerships and international online forums can further reduce duplication [Zhang YH, Jia X, Lin H, Tan X. Be careful! Avoiding duplication: a case study. J Zhejiang Univ Sci B. Apr 2013;14(4):355-358. [FREE Full text] [CrossRef] [Medline]46,Hammer B, Virgili E, Bilotta F. Evidence-based literature review: de-duplication a cornerstone for quality. World J Methodol. Dec 20, 2023;13(5):390-398. [FREE Full text] [CrossRef] [Medline]47]. Preregistration of studies and the adoption of open science practices enhance transparency and allow researchers to identify existing projects.

We also highlight the critical role of scientific diplomats in fostering international collaboration and multilateral partnerships. By using concepts, norms, and values in scientific diplomacy, typically used in political diplomacy, we take actions to facilitate international scientific collaboration (eg, facilitating the negotiation of research and development agreements and exchange programs or services, or enabling the establishment of international research infrastructure) [Gluckman P, Quirion R, Sachs J, van Jaarsveld AS. Scientific diplomacy keeps reason alight in dark times. Nature. Apr 19, 2022;604(7906):425. [CrossRef] [Medline]48]. Although not frequently known by senior researchers, this labor class has becoming more frequently needed and common over the last years as scientific diplomats are a critical part of fostering and initiating discussions where science, innovation, and technological advancement intersect with international relations and policy [France diplomacy. Ministère de l'Europe et des Affaires étrangères. URL: https://www.diplomatie.gouv.fr/en/french-foreign-policy/scientific-and-academic-diplomacy/ [accessed 2024-10-17] 49]. These professionals are commonly active researchers who use diplomatic responsibilities to not only influence (locally or internationally), but to also represent national interests (commonly known as diplomat scientist) to other nations, or they might potentially become specialized in a particular domain of expertise (ie, science, technology, and innovation policies in international collaboration) [Ruffini PB. Conceptualizing science diplomacy in the practitioner-driven literature: a critical review. Humanit Soc Sci Commun. Oct 14, 2020;7(1):23. [CrossRef]50]. In addition, scientific diplomats help establish shared and standardized protocols, promote the adoption of best practices, and ensure the long-term sustainability of international research network [Jacobsen LL, Olšáková D. Diplomats in science diplomacy: promoting scientific and technological collaboration in international relations*. Ber Wiss. Dec 11, 2020;43(4):465-472. [CrossRef] [Medline]51]. These efforts contribute to more efficient and impactful scientific strategies on a global scale.

Cluster Analysis and Research Trends

We selected specific clusters for detailed and comprehensive analysis. Notably, our analysis of these clusters reveals relevant and timely discussions, particularly regarding their alignment with current trends in DHTs for dementia care and their implications for future research directions.

First, regarding the clusters identified in our assessment of the most cited journals in the field of dementia and DHTs, we observed a diverse landscape. Interdisciplinary collaboration, evidence-based development, and personalized care emerged as major themes. Notably, the clusters highlight the integration of psychological, social, clinical, and technological aspects, with increasing emphasis on using DHTs for mental health support (for both patients or formal and informal health care providers), sensor technologies for real-time monitoring, and systematic reviews to evaluate the efficacy of these tools.

On the basis of these findings, future research should prioritize not only collaborative research development but also the synergic integration of DHTs into health care systems, particularly in nursing and clinical practice, while always considering ethical concerns, such as privacy and the specific implementation challenges for different labor sectors. Another cluster we analyzed involved the most prolific countries in the field of dementia and DHTs. This revealed a complex global network, with leading research hubs forming distinct clusters. High-income countries, such as the United Kingdom (cluster 3), and the United States and Australia (cluster 1), stand out with the highest number of reviews and citations, underscoring their central role in advancing scientific knowledge related to DHTs for dementia care. Emerging middle- or high-income countries, including India and South Korea, respectively, are becoming notable research hubs in Asia, expanding DHT-related research beyond traditional Western centers.

Our data also point to growing international collaboration, particular among European countries, likely driven by concerns about populational aging in the region and the European Union funding programs that require a multicenter approach to research. This global distribution emphasizes the importance of fostering international research partnerships to ensure that DHT innovations are accessible and applicable worldwide, not just in high-income countries.

Finally, our cluster analysis highlighted key institutions and research groups active in the field of dementia and DHTs. These findings underscore the importance of a multidisciplinary approach to advancing dementia care through digital health, stressing the need for collaboration across technology, health care services, ethics, and human factors to design effective, sustainable solutions.

This review predominantly included studies conducted and produced by researchers located in high-income countries. The impact of dementia and neurocognitive impairment has been noteworthy in nations where the gross national income per capita is more than US $12,376 [International development, poverty, and sustainability. World Bank. URL: https://www.worldbank.org/en/home [accessed 2024-05-10] 52]. However, the rising prevalence of dementia is not limited to high-income settings. Recent estimates suggest that by 2030, more than 75 million individuals with dementia will reside in low- and middle-income countries [Ferri CP, Jacob KS. Dementia in low-income and middle-income countries: different realities mandate tailored solutions. PLoS Med. Mar 28, 2017;14(3):e1002271. [FREE Full text] [CrossRef] [Medline]53]. While our analysis included studies from various nations, there remains a need for more global and collaborative effort beyond the regions currently leading this research. These efforts should focus on evaluating the diverse roles of DHTs in dementia care, taking into action regional specificities, needs, and expectations. Furthermore, this review highlights global regions that do not feature highly in the results; this is a call for action to researchers, organizations, and policy makers in the respective regions (Latin America, Asia, Africa, Central and Eastern Europe, and so forth) to explore and conduct research in this arena.

The coauthorship and collaboration network analysis highlighted the most prolific collaboration between authors and institutions with the most relevant reviews on DHTs for dementia care. Rose-Marie Dröes, Julian Hirt, and Minmin Leng emerged as critical global investigators. At the same time, institutional productivity showed that the College of Nursing, Kaohsiung Medical University, Kaohsiung, Taiwan, and the Dementia Services Development Centre Wales, Bangor University, United Kingdom are leading contributors in this arena. By understanding this trend in productivity over time, we can further evaluate their influence on this inter and multidisciplinary field.

Implications for Future Research, Clinicians, Researchers, and Policy Makers

Our study systematically evaluates the extent to which DHTs have been described as potential interventions in dementia care. For several DHT modalities, particularly those with substantial scientific output, these technologies have provided clinicians with a strong evidence base to inform their clinical practices, enabling them to integrate (or reject) these tools for people living with dementia [Manoj Kumar L, George RJ. Bibliometric analysis for medical research. Indian J Psychol Med. May 11, 2023;45(3):277-282. [FREE Full text] [CrossRef] [Medline]54]. However, further detailed assessments are needed to determine whether various digital interventions adequately address the physical, cognitive, and social needs of people living with dementia and their caregivers.

Our bibliometric analysis highlights the growing and evolving body of literature on the critical role of DHTs in advancing dementia care, particularly within the context of international health priorities, such as those endorsed by the WHO’s Global Digital Health Strategy 2020 to 2025 [Global strategy on digital health 2020-2025. World Health Organization. 2021. URL: https://www.who.int/docs/default-source/documents/gs4dhdaa2a9f352b0445bafbc79ca799dce4d.pdf [accessed 2024-04-29] 55]. Given the rising global incidence of dementia, there is an imperative demand for innovative solutions that can be scaled globally, especially in low- and middle-income countries, where the burden of dementia-related disorders is expected to significantly increase by 2030.

The WHO’s strategy on digital health emphasizes the importance of leveraging DHTs through equitable process, aiming to achieve universal health coverage, enhance research, and improve the quality of care [Global strategy on digital health 2020-2025. World Health Organization. 2021. URL: https://www.who.int/docs/default-source/documents/gs4dhdaa2a9f352b0445bafbc79ca799dce4d.pdf [accessed 2024-04-29] 55]. These principles align directly with the potential of DHTs for dementia care, as observed in our study. With most research initiatives concentrated in high-income countries, future research should focus on the tailored development, long-term evaluation, and implementation of DHTs in diverse settings, including resource-limited environments.

Policy makers must consider the implications of our research for establishing and sustaining international research collaborations, as well as the need for interventions specifically designed to address the challenges faced by different populations. Moreover, the “publish or perish” paradigm prevalent in academia contributes to research duplication, which should be mitigated through various strategies, as previously discussed [Rawat S, Meena S. Publish or perish: where are we heading? J Res Med Sci. Feb 2014;19(2):87-89. [FREE Full text] [Medline]56]. These proposed actions are aligned with the WHO’s initiatives for improving global research and advancing industrial technologies, under the Sustainable Development Goals 9. By aligning future research with the priorities outlined in the WHO Global Digital Health Strategy, stakeholders can support the development of comprehensive, evidence-informed public health policies that promote the equitable adoption of DHTs in dementia care.

Strengths and Limitations

This bibliometric review has provided evidence of the modalities of DHTs in the context of dementia. The findings highlight domains that still require further evaluation and geographic regions that are leading in this arena but also require further investigation at a local level. In addition, we did not observe any previous systematic reviews evaluating the role of telemedicine and remote telemonitoring interventions on dementia care. There is a paucity in the current body of literature pertaining to the appraisal of the applicability of big data analytics regarding health-related decision-making. These analytics have been shown to provide important clinical insights that have the potential to support the development of effective therapeutic strategies and preventive measures. There is a planned body of work relating to a series of papers whereby the authors intend to evaluate the potential of these 2 modalities of digital interventions, encompassing multiple prospective domains and influencing health, economic, or social outcomes. We believe that by identifying the knowledge gap, we will facilitate the provision of care for both people living with dementia and their caregivers. Moreover, we anticipate future results will alleviate the burden of dementia on international health care systems and optimize resource allocation toward programs that adequately supply patients and social actors involved in care. This in turn has the potential to furnish national governments, local authorities, and municipalities with greater insights to tackle respective priorities and strategies. This too may aid policy makers in identifying financial resources [Dikken J, van den Hoven RF, van Staalduinen WH, Hulsebosch-Janssen LM, van Hoof J. How older people experience the age-friendliness of their city: development of the age-friendly cities and communities questionnaire. Int J Environ Res Public Health. Sep 20, 2020;17(18):6867. [FREE Full text] [CrossRef] [Medline]57] at a local level in the context of age-friendly cities and communities [Marston HR, van Hoof J, Yon Y. Digitalising the built environment for all generations: a new paradigm for equity and inclusive age-friendly cities and communities. Indoor Built Environ. May 19, 2023;33(2):213-217. [CrossRef]58].

This review used a solid and comprehensive methodology, although there are limitations. First, in this bibliometric analysis, reviews were included if they were located in the Scopus database, and a few identified records were not indexed in this database. Because we solely focused on the Scopus database, we may have missed key literature that might hinder the generalizability of our findings. However, we believe that the core reported findings would not be significantly changed. Second, while the observed keywords and identifiers analysis offered important insights regarding research topics that have received scholarly attention over time, further detailed assessments of the shortlisted publications may provide more specific information associated with the interface between digital health and dementia care. Third, our study’s selection criterion (exclusively focusing on systematic and scoping reviews) may have slightly introduced selection bias due to the exclusion of narrative and integrative reviews. Although commonly labeled as less rigorous in their methodology, they could still offer some additional perspectives and insights into emerging tendencies, particularly in a field such as digital health, which is constantly evolving. However, we believe that maintaining our work based on better methodologically designed records increases the validity and credibility of our study. In addition, potential publication bias must be acknowledged, especially, with the repeated similar reviews that may overrepresent certain technologies or outcomes. Finally, we did not assess the methodological quality of systematic reviews identified in our screening because of the high volume of eligible reviews. However, we will prioritize the quality appraisal in the process of evidence synthesis by following the PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) guidelines to report the upcoming systematic review.

Conclusions

This review indicates that there has been an increase in both dementia- and DHT-related publications since the first review in 2002, with a more prominent growth observed after 2017. Despite the diverse approach of DHT modalities for dementia care, authors have focused on mobile health, virtual reality, AI, and sensor technologies. Analysis revealed prominent authors and institutions studying the intersection between digital health and dementia. High-income countries were identified as the leaders in publishing and maintaining research collaborations on this topic. Overall, this analysis provides an initial point of reference for policy makers and academics who wish to conduct research or collaborate on funding calls to understand the contemporary landscape in a bid to undertake innovative and applied research that will primarily benefit people living with dementia, their caregivers, and service provision and resources. We particularly recommend prioritizing the exploration of underrepresented DHTs for research questions and expanding research in low- and middle-income countries to ensure alignment with global equity principles. In addition, it is essential for the scientific and governmental communities to develop frameworks that effectively integrate DHTs into dementia care, guided by the principles of accessibility, affordability, and user friendliness. This review has illustrated emerging global trends and identified areas where future research should focus, especially considering the current emphasis on high-income countries and the remaining knowledge gaps.

Acknowledgments

The authors wish to thank Anneliese Arno (Evidence for Policy & Practice Centre, University College London, London, United Kingdom, and School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia) for granting complimentary access to Covidence (Veritas Health Innovation). The authors affiliated with the World Health Organization (WHO) are alone responsible for the views expressed in this publication and they do not necessarily represent the decisions or policies of the WHO.

This work was supported by the European Commission under the project "Supporting Member States in strengthening health information systems and boosting health data governance".

Data Availability

The datasets generated and analyzed during this study are available from the corresponding author on reasonable request.

Conflicts of Interest

IJBdN, IW, and HMA are active Cochrane members.

Multimedia Appendix 1

BIBLIO checklist for reporting bibliometric reviews of biomedical literature.

DOCX File , 24 KB

Multimedia Appendix 2

Search strategies. The search was conducted on February 20, 2024.

DOCX File , 33 KB

Multimedia Appendix 3

Identified overviews or umbrella reviews during the second screening phase.

DOCX File , 15 KB

Multimedia Appendix 4

Reasons for excluding shortlisted studies.

XLSX File (Microsoft Excel File), 31 KB

Multimedia Appendix 5

References without a digital object identifier.

DOCX File , 16 KB

Multimedia Appendix 6

References not indexed in Scopus.

DOCX File , 18 KB

  1. Loy CT, Schofield PR, Turner AM, Kwok JB. Genetics of dementia. Lancet. Mar 01, 2014;383(9919):828-840. [CrossRef] [Medline]
  2. GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. May 2019;18(5):459-480. [FREE Full text] [CrossRef] [Medline]
  3. Aranda MP, Kremer IN, Hinton L, Zissimopoulos J, Whitmer RA, Hummel CH, et al. Impact of dementia: health disparities, population trends, care interventions, and economic costs. J Am Geriatr Soc. Jul 10, 2021;69(7):1774-1783. [FREE Full text] [CrossRef] [Medline]
  4. Wimo A, Seeher K, Cataldi R, Cyhlarova E, Dielemann JL, Frisell O, et al. The worldwide costs of dementia in 2019. Alzheimers Dement. Jul 08, 2023;19(7):2865-2873. [FREE Full text] [CrossRef] [Medline]
  5. World Health Organization. World Health Organization endorses global action plan on rising incidence of dementia. Nurs Older People. Jun 30, 2017;29(6):7-7. [CrossRef] [Medline]
  6. Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. Aug 08, 2020;396(10248):413-446. [FREE Full text] [CrossRef] [Medline]
  7. Senbekov M, Saliev T, Bukeyeva Z, Almabayeva A, Zhanaliyeva M, Aitenova N, et al. The recent progress and applications of digital technologies in healthcare: a review. Int J Telemed Appl. Dec 3, 2020;2020:8830200-8830218. [FREE Full text] [CrossRef] [Medline]
  8. Brookman R, Parker S, Hoon L, Ono A, Fukayama A, Matsukawa H, et al. Technology for dementia care: what would good technology look like and do, from carers’ perspectives? BMC Geriatr. Dec 16, 2023;23(1):867. [CrossRef]
  9. Classification of digital interventions, services and applications in health: a shared language to describe the uses of digital technology for health. 2nd edition. World Health Organization. URL: https://iris.who.int/bitstream/handle/10665/373581/9789240081949-eng.pdf?sequence=1 [accessed 2024-04-29]
  10. WHO’s work on the UN decade of healthy ageing (2021-2030). World Health Organization. URL: https://www.who.int/initiatives/decade-of-healthy-ageing [accessed 2024-04-17]
  11. Global sustainable development report 2023: times of crisis, times of change - science for accelerating transformations to sustainable development. United Nations. URL: https://sdgs.un.org/sites/default/files/2023-09/FINAL%20GSDR%202023-Digital%20-110923_1.pdf [accessed 2024-04-29]
  12. Comprehensive overview of digital health interventions for dementia: a synthesis of systematic and scoping reviews across prevention, diagnosis, treatment, and care support team. National Institute for Health Research. URL: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=511241 [accessed 2024-04-29]
  13. Ellegaard O, Wallin JA. The bibliometric analysis of scholarly production: how great is the impact? Scientometrics. Jul 28, 2015;105(3):1809-1831. [CrossRef]
  14. Montazeri A, Mohammadi S, Hesari PM, Ghaemi M, Riazi H, Sheikhi-Mobarakeh Z. Preliminary guideline for reporting bibliometric reviews of the biomedical literature (BIBLIO): a minimum requirements. Syst Rev. Dec 15, 2023;12(1):239. [FREE Full text] [CrossRef] [Medline]
  15. Hodgkinson B, Koch S, Nay R, Lewis M. Managing the wandering behaviour of people living in a residential aged care facility. Int J Evid Based Healthc. Dec 2007;5(4):406-436. [CrossRef] [Medline]
  16. Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. Oct 02, 2018;169(7):467-473. [FREE Full text] [CrossRef] [Medline]
  17. Basheer A. The art and science of writing narrative reviews. Int J Adv Med Health Res. 2022;9(2):124-126. [CrossRef]
  18. Bukar UA, Sayeed MS, Razak SF, Yogarayan S, Amodu OA, Mahmood RA. A method for analyzing text using VOSviewer. MethodsX. Dec 2023;11:102339. [FREE Full text] [CrossRef] [Medline]
  19. Dementia: a public health priority. World Health Organization and Alzheimer’s Disease International. URL: https://iris.who.int/bitstream/handle/10665/75263/9789241564458_eng.pdf?sequence=1%3E [accessed 2024-04-29]
  20. Arksey H, O'Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. Feb 2005;8(1):19-32. [CrossRef]
  21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5th edition. New York, NY. American Psychiatric Publishing; 2013.
  22. Kales HC, Gitlin LN, Lyketsos CG. Assessment and management of behavioral and psychological symptoms of dementia. BMJ. Mar 02, 2015;350:h369. [FREE Full text] [CrossRef] [Medline]
  23. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd edition. New York, NY. Routledge Academic; 1988.
  24. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. Jul 21, 2009;6(7):e1000097. [FREE Full text] [CrossRef] [Medline]
  25. Global action plan on the public health response to dementia 2017-2025. World Health Organization. URL: https:/​/www.​who.int/​publications/​i/​item/​global-action-plan-on-the-public-health-response-to-dementia-2017-2025 [accessed 2025-01-12]
  26. Bemelmans R, Gelderblom GJ, Jonker P, de Witte L. How to use robot interventions in intramural psychogeriatric care: a feasibility study. Appl Nurs Res. May 2016;30:154-157. [CrossRef] [Medline]
  27. Lampit A, Hallock H, Valenzuela M. Computerized cognitive training in cognitively healthy older adults: a systematic review and meta-analysis of effect modifiers. PLoS Med. Nov 2014;11(11):e1001756. [FREE Full text] [CrossRef] [Medline]
  28. Mordoch E, Osterreicher A, Guse L, Roger K, Thompson G. Use of social commitment robots in the care of elderly people with dementia: a literature review. Maturitas. Jan 2013;74(1):14-20. [CrossRef] [Medline]
  29. Moyle W, Jones C, Murfield J, Thalib L, Beattie E, Shum D, et al. Effect of a robotic seal on the motor activity and sleep patterns of older people with dementia, as measured by wearable technology: a cluster-randomised controlled trial. Maturitas. Apr 2018;110:10-17. [FREE Full text] [CrossRef] [Medline]
  30. Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. Dec 05, 2016;5(1):210. [FREE Full text] [CrossRef] [Medline]
  31. Abdi J, Al-Hindawi A, Ng T, Vizcaychipi MP. Scoping review on the use of socially assistive robot technology in elderly care. BMJ Open. Feb 12, 2018;8(2):e018815. [FREE Full text] [CrossRef] [Medline]
  32. Astell AJ, Bouranis N, Hoey J, Lindauer A, Mihailidis A, Nugent C, et al. Technology and Dementia Professional Interest Area. Technology and dementia: the future is now. Dement Geriatr Cogn Disord. 2019;47(3):131-139. [FREE Full text] [CrossRef] [Medline]
  33. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. Mar 29, 2021;372:n71. [FREE Full text] [CrossRef] [Medline]
  34. Lund H, Juhl C, Christensen R. Systematic reviews and research waste. Lancet. Jan 09, 2016;387(10014):123-124. [CrossRef] [Medline]
  35. Wesselman LM, Hooghiemstra AM, Schoonmade LJ, de Wit MC, van der Flier WM, Sikkes SA. Web-based multidomain lifestyle programs for brain health: comprehensive overview and meta-analysis. JMIR Ment Health. Apr 09, 2019;6(4):e12104. [FREE Full text] [CrossRef] [Medline]
  36. Ionescu A, Ştefănescu E, Strilciuc S, Grad DA, Mureşanu D. Eyes on dementia: an overview of the interplay between eye movements and cognitive decline. J Med Life. May 2023;16(5):642-662. [FREE Full text] [CrossRef] [Medline]
  37. Eost-Telling C, Yang Y, Norman G, Hall A, Hanratty B, Knapp M, et al. Digital technologies to prevent falls in people living with dementia or mild cognitive impairment: a rapid systematic overview of systematic reviews. Age Ageing. Jan 02, 2024;53(1):23. [FREE Full text] [CrossRef] [Medline]
  38. Cai Z, Ma Y, Li L, Lu GZ. Effects of exergaming in older individuals with mild cognitive impairment and dementia: a systematic review and meta-analysis. Geriatr Nurs. May 2023;51:351-359. [CrossRef] [Medline]
  39. Mura G, Carta MG, Sancassiani F, Machado S, Prosperini L. Active exergames to improve cognitive functioning in neurological disabilities: a systematic review and meta-analysis. Eur J Phys Rehabil Med. Jun 2018;54(3):450-462. [FREE Full text] [CrossRef] [Medline]
  40. Zhao Y, Feng H, Wu X, Du Y, Yang X, Hu M, et al. Effectiveness of exergaming in improving cognitive and physical function in people with mild cognitive impairment or dementia: systematic review. JMIR Serious Games. Jun 30, 2020;8(2):e16841. [FREE Full text] [CrossRef] [Medline]
  41. Katsura M, Kuriyama A, Tada M, Yamamoto K, Furukawa TA. Redundant systematic reviews on the same topic in surgery: a study protocol for a meta-epidemiological investigation. BMJ Open. Aug 21, 2017;7(8):e017411. [FREE Full text] [CrossRef] [Medline]
  42. Lund H, Robinson KA, Gjerland A, Nykvist H, Drachen TM, Christensen R, et al. Meta-research evaluating redundancy and use of systematic reviews when planning new studies in health research: a scoping review. Syst Rev. Nov 15, 2022;11(1):23. [CrossRef]
  43. Ioannidis JP. The mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses. Milbank Q. Sep 13, 2016;94(3):485-514. [FREE Full text] [CrossRef] [Medline]
  44. Moher D. The problem of duplicate systematic reviews. BMJ. Aug 14, 2013;347(aug14 4):f5040. [CrossRef] [Medline]
  45. Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series. New York, NY. The Cochrane Collaboration; 2022.
  46. Zhang YH, Jia X, Lin H, Tan X. Be careful! Avoiding duplication: a case study. J Zhejiang Univ Sci B. Apr 2013;14(4):355-358. [FREE Full text] [CrossRef] [Medline]
  47. Hammer B, Virgili E, Bilotta F. Evidence-based literature review: de-duplication a cornerstone for quality. World J Methodol. Dec 20, 2023;13(5):390-398. [FREE Full text] [CrossRef] [Medline]
  48. Gluckman P, Quirion R, Sachs J, van Jaarsveld AS. Scientific diplomacy keeps reason alight in dark times. Nature. Apr 19, 2022;604(7906):425. [CrossRef] [Medline]
  49. France diplomacy. Ministère de l'Europe et des Affaires étrangères. URL: https://www.diplomatie.gouv.fr/en/french-foreign-policy/scientific-and-academic-diplomacy/ [accessed 2024-10-17]
  50. Ruffini PB. Conceptualizing science diplomacy in the practitioner-driven literature: a critical review. Humanit Soc Sci Commun. Oct 14, 2020;7(1):23. [CrossRef]
  51. Jacobsen LL, Olšáková D. Diplomats in science diplomacy: promoting scientific and technological collaboration in international relations*. Ber Wiss. Dec 11, 2020;43(4):465-472. [CrossRef] [Medline]
  52. International development, poverty, and sustainability. World Bank. URL: https://www.worldbank.org/en/home [accessed 2024-05-10]
  53. Ferri CP, Jacob KS. Dementia in low-income and middle-income countries: different realities mandate tailored solutions. PLoS Med. Mar 28, 2017;14(3):e1002271. [FREE Full text] [CrossRef] [Medline]
  54. Manoj Kumar L, George RJ. Bibliometric analysis for medical research. Indian J Psychol Med. May 11, 2023;45(3):277-282. [FREE Full text] [CrossRef] [Medline]
  55. Global strategy on digital health 2020-2025. World Health Organization. 2021. URL: https://www.who.int/docs/default-source/documents/gs4dhdaa2a9f352b0445bafbc79ca799dce4d.pdf [accessed 2024-04-29]
  56. Rawat S, Meena S. Publish or perish: where are we heading? J Res Med Sci. Feb 2014;19(2):87-89. [FREE Full text] [Medline]
  57. Dikken J, van den Hoven RF, van Staalduinen WH, Hulsebosch-Janssen LM, van Hoof J. How older people experience the age-friendliness of their city: development of the age-friendly cities and communities questionnaire. Int J Environ Res Public Health. Sep 20, 2020;17(18):6867. [FREE Full text] [CrossRef] [Medline]
  58. Marston HR, van Hoof J, Yon Y. Digitalising the built environment for all generations: a new paradigm for equity and inclusive age-friendly cities and communities. Indoor Built Environ. May 19, 2023;33(2):213-217. [CrossRef]


AI: artificial intelligence
DHT: digital health technology
DOI: digital object identifier
IF: impact factor
PRISMA: Preferred Reporting Items for Systematic reviews and Meta-Analyses
WHO: World Health Organization


Edited by J Torous; submitted 17.07.24; peer-reviewed by S Sheth, Z Guo; comments to author 16.08.24; revised version received 09.11.24; accepted 27.11.24; published 10.02.25.

Copyright

©Hebatullah Abdulazeem, Israel Júnior Borges do Nascimento, Ishanka Weerasekara, Amin Sharifan, Victor Grandi Bianco, Ciara Cunningham, Indunil Kularathne, Genevieve Deeken, Jerome de Barros, Brijesh Sathian, Lasse Østengaard, Frederique Lamontagne-Godwin, Joost van Hoof, Ledia Lazeri, Cassie Redlich, Hannah R Marston, Ryan Alistair Dos Santos, Natasha Azzopardi-Muscat, Yongjie Yon, David Novillo-Ortiz. Originally published in JMIR Mental Health (https://mental.jmir.org), 10.02.2025.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Mental Health, is properly cited. The complete bibliographic information, a link to the original publication on https://mental.jmir.org/, as well as this copyright and license information must be included.